Lupin (LUPIN)
STALWARTFairStock Score: 75/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,341.4 |
| Market Cap | ₹1,05,206.78 Cr |
| P/E Ratio | 21.15 |
| ROCE | 21.3% |
| ROE | 27% |
| Dividend Yield | 0.52% |
| Profit Growth | 61.93% |
| Debt/Equity | 0.32 |
| Sales Growth | 18.86% |
| Free Cash Flow | ₹-1,17,200 Cr |
| Promoter Holding | 46.89% |
| 52-Week Range | ₹1,836.8 — ₹2,494 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹376.41 |
Lupin trades with a P/E ratio of 21.15, ROCE of 21.3%, ROE of 27%, profit growth of 61.93%, debt-to-equity of 0.32. The FairStock Score of 75/100 reflects strong fundamentals across multiple dimensions.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer